Rovira 2004.
Study characteristics | |||
Patient sampling | Prospective; consecutive series of patients | ||
Patient characteristics and setting | 74 participants
Age ranged from 15 to 60 years
61% males
Spain Adults undergoing allogeneic haematopoietic stem cell transplantation in institution and adult outpatients receiving immunosuppressive therapy. Inpatients were screened twice weekly; outpatients weekly, if possible Representative spectrum? Yes: adults undergoing allogeneic haematopoietic stem cell transplantation |
||
Index tests | Platelia. Serum was monitored twice a week until discharge or death. Outpatients were monitored weekly where possible. Positive was above 1.5 and negative was below 1.0. In between was undetermined. Total of 832 samples from 74 patients. Positive was one or more positive; negative was all negative | ||
Target condition and reference standard(s) | Invasive aspergillosis, as defined by EORTC criteria (Ascioglu 2002) Incorporation avoided? Yes: Aspergillus galactomannan antigen test results were excluded as microbiologic criteria Acceptable reference standard? Yes: EORTC criteria (Ascioglu 2002) |
||
Flow and timing | Time interval not reported Partial verification avoided? Yes: all patients were classified according to reference criteria Withdrawals explained? Unclear Uninterpretable results reported? Yes: when a sample was undetermined, an additional sample was immediately tested |
||
Comparative | |||
No patients per category | 1 proven, 5 probable, 2 possible, 66 no IA | ||
Notes | Clinical course and timelines for 8 patients Sponsoring? Governance funds and a leukaemia foundation |
||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Low | Low | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Low | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Low | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Low |